Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

BACKGROUND/AIMS: Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons. Newly developed directly acting antivirals (DAAs) have been used to treat chronic hepatitis C without severe adverse effects and have achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Kwang Il, Yun, Byung Chul, Li, Weiquan James, Lee, Sang Uk, Han, Byung Hoon, Park, Eun Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381840/
https://www.ncbi.nlm.nih.gov/pubmed/28259115
http://dx.doi.org/10.3350/cmh.2016.0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381840/
https://www.ncbi.nlm.nih.gov/pubmed/28259115
http://dx.doi.org/10.3350/cmh.2016.0052

Ejemplares similares